What is the main business of Diagnostyka Histopatologiczna i Molekularna?

The main business activity of Diagnostyka Histopatologiczna i Molekularna focuses on specialist medical practice activities.

When was the company founded?

The company was registered in the Polish National Court Register (KRS) on July 16, 2013.

Where is the headquarters located?

The headquarters is located at: Złota 61, 00-819 Warszawa.

What is the share capital?

The share capital of the company is PLN 10,000 (approx. $2,701).

What period do the latest financial data cover?

The latest available financial statement covers the period from January 1, 2019 to December 31, 2019.

What revenue was generated?

The company reported a revenue of $0 in 2019, which is a decrease of 100.0% compared to 2018.

No, in 2019 the company was not profitable, reporting a net loss of $10,705. For comparison, in 2018 the loss was $20,361, meaning the company reduced its loss by 44.1%.

Which cost dominates operating expenses?

The largest operating cost category falls under other operating costs. This category amounted to $4,954 in 2019, representing 46% of all operating expenses.

Diagnostyka Histopatologiczna i Molekularnasp. z o.o.

Specialist medical practice activities

KRS: NIP: REGON:

Overview

Status

Suspended

Registry date

2013-07-16

Share capital

10,000.00 PLN

Registered address

Złota 61/100, 00-819 Warszawa, Poland

Electronic delivery address

AE:PL-15669-92003-CCSFR-14

Financials

Revenue history

Filing timeliness

No financial statement for 2020 – the filing deadline has passed. 1 of 2 financial statements was filed late (for 2018, 1 day late).

2020not filed
201930/09/2020
201816/07/2019

Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2019.

Results vs industry

Revenue

This companyUSD 0.16MedianUSD 443.18kAverageUSD 1.74m

Net profit

This companyUSD -10.70kMedianUSD 14.27kAverageUSD 128.63k

Operating costs

This companyUSD 10.68kMedianUSD 395.77kAverageUSD 1.56m

Assets

This companyUSD 4.77kMedianUSD 173.69kAverageUSD 1.02m

Industry

Trademarks

Diagnostyka Histopatologiczna i Molekularna currently holds no active trademarks with the Polish Patent Office. 1 mark has expired or was not registered. The first mark was filed in 2015.

Mark	Number	Classes	Status	Protected until
NEWPATHOLOGY.COM	Z.439821	35, 41, 44	Not registered	–

Mark	Protected until
NEWPATHOLOGY.COM	–

Authorized Representatives

Artur Bartczak – President of the Management Board

Manner of representation

President of the Management Board independently, or the President of the Management Board acting jointly with a member of the management board.

Ownership

Owner	Shares	Share value	Stake
Artur Bartczakage 49	67	$1,809.83	67%
Paweł Piotr Kołodziejage 59	10	$270.12	10%
Others	23	$621.29	23%

Beneficial owners

Person	Rights

Bank accounts

Was a VAT taxpayer from 2013-07-12 to 2025-09-03.

Reason for removal: Art. 96 ust. 9 pkt 3 (data provided in the VAT-R registration form is false)

Debt

No entries in the National Debtors Register (KRZ).

Public aid

No public aid cases recorded in the last 10 years.

Competitors

Name	Revenue	Website
Medicoversp. z o.o.	$720,657,064.54	medicover.pl
Centrum Medyczne Enel-MedS.A.	$216,569,060.77	enel.pl
Medicalgorithmics Polskasp. z o.o.	$822,579.08	medicalgorithmics.pl
AurismedS.A.	$477,685.18	aurismed.pl
Orlik Zdrowie i Edukacjasp. z o.o.	$257,578.35	przychodnia-orlik.pl
Onkomedicasp. z o.o.	$69,344.55	onkomedica.pl
Biocells Medicalsp. z o.o.	$11,508.17	biocellsmedical.com
Bodyclinicsp. z o.o.	$3,758.46	bodyclinic.pl
Regenerumclinicsp. z o.o.	$1,427.86	regenerumclinic.pl
Civilmedsp. z o.o.	–	civilmed.pl